New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2013
12:14 EDTZIOPZiopharm confirms PFS is endpoint in palifosfamide trial, Feuerstein says
Ziopharm confirmed that progression-free survival, or PFS, is now an acceptable endpoint for approval in palifosfamide's Phase III trial, The Street's Adam Feuerstein said via Twitter, citing a company spokesperson. Shares of Ziopharm are up 5% to $5.53 in early afternoon trading.
News For ZIOP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
10:29 EDTZIOPOptions with decreasing implied volatility
Options with decreasing implied volatility: ZIOP KING ARIA CTRP WTW VHC XON KERX VIPS JCP
10:16 EDTZIOPHigh option volume stocks
Subscribe for More Information
May 19, 2015
11:59 EDTZIOPOptions with decreasing implied volatilit
Subscribe for More Information
May 18, 2015
10:37 EDTZIOPOptions with decreasing implied volatility
Options with decreasing implied volatility: NLNK ARWR CTRP ZIOP CLNE ARIA VHC AOL KING XON PEIX
May 14, 2015
05:52 EDTZIOPMizuho expects CAR T stocks to be volatile after ASCO abstract
Subscribe for More Information
May 13, 2015
10:02 EDTZIOPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: A.O. Smith (AOS) initiated with a Hold at Gabelli... Bellicum Pharmaceuticals (BLCM) initiated with a Neutral at Guggenheim... Criteo (CRTO) initiated with a Hold at Evercore ISI... FleetCor (FLT) initiated with a Buy at Monness Crespi... Franco-Nevada (FNV) initiated with a Buy at Canaccord... Horizon Technology (HRZN) initiated with an Outperform at Oppenheimer... Merrimack (MACK) initiated with a Buy at Guggenheim... Mobileye (MBLY) initiated with a Sector Weight at Pacific Crest... Monroe Capital (MRCC) initiated with an Outperform at Oppenheimer... Royal Gold (RGLD) initiated with a Hold at Canaccord... Silver Wheaton (SLW) initiated with a Buy at Canaccord... U.S. Concrete (USCR) initiated with a Buy at Stifel... Ziopharm (ZIOP) initiated with a Neutral at Guggenheim.
06:26 EDTZIOPZiopharm initiated with a Neutral at Guggenheim
May 12, 2015
09:23 EDTZIOPIntrexon CEO says Ziopharm acqusition could be 'attractive' in future
Subscribe for More Information
05:55 EDTZIOPIntrexon price target lowered to $45 from $50 at Mizuho
Subscribe for More Information
May 11, 2015
16:40 EDTZIOPIntrexon declares special dividend of Ziopharm shares
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use